ArticlePalliative & supportive care2025
Benefits of duloxetine may outweigh risks in a patient with hormone-positive breast cancer.
Gustavo Scannapieco Mastroleo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it